Answers are grounded in this paper and cite their sources.
Systematic review analyzes temporal artery biopsy positivity by race in giant cell arteritis, indicating significant disparities.
This systematic review and meta-analysis investigated whether temporal artery biopsy (TAB) positivity differs by race and ethnicity among patients undergoing TAB for suspected giant cell arteritis (GCA). The review was registered on PROPSERO (CRD420251236971) and followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses. MEDLINE, Embase, and the Cochrane Library were searched from inception to 19 February 2025. Included studies reported TAB prevalence or positivity stratified by race/ethnicity among patients biopsied for suspected GCA. Two reviewers independently screened and extracted data. Risk of bias was assessed using Risk Of Bias In Non-randomized Studies of Interventions. Random-effects meta-analyses pooled prevalence and risk ratios (RR). Certainty of evidence was rated using Grading of Recommendations Assessment, Development and Evaluation. Sixteen studies (n = 9,045) were included. Pooled TAB positivity was 0.07 in Black and African American patients (95% CI, 0.05–0.11; I2 = 0%) and 0.07 in Arab patients (95% CI, 0.04–0.11; I2 = 0%), compared with 0.28 in White patients (95% CI, 0.22–0.34; I2 = 74.8%) and 0.88 in Jewish patients (95% CI, 0.80–0.94). Black and African American patients were less likely than White patients to have a positive TAB (RR, 0.38; 95% CI, 0.25–0.58; I2 = 0%), and Hispanic/Latino/Spanish patients were also less likely (RR, 0.49; 95% CI, 0.27–0.88; I2 = 44.3%). Low-certainty evidence suggests TAB positivity is higher among White patients than among Black and African American or Hispanic/Latino/Spanish patients who undergo TAB for suspected GCA.
No takes yet. Share an insight, caveat, or question.
Butt et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: